US Drug Recall Register
Class II · Moderate risk Terminated Initiated Mar 25, 2013 (13 years ago)

Nandrolone Decanoate Injectable

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

What was recalled

Nandrolone Decanoate Injectable, compounded by Pallimed Solutions Pharmacy, Woburn, MA

Recalling firm
Pallimed Solutions
Origin
MA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-873-2013

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Nandrolone recalls

See all
Class II · Moderate risk Ongoing

Nandrolone Decanoate 200mg/mL

Reason Lack of Assurance of Sterility

TMC Acquisition LLC dba Tailor Made Compounding D-1220-2022
Class III · Low risk Terminated

Nandrolone Decanoate

Reason Subpotent Drug

Fagron, Inc NDC 0395-8212-43 D-0866-2022
Class III · Low risk Terminated

Nandrolone Decanoate

Reason Subpotent Drug

Fagron, Inc NDC 0395-8212-56 D-0865-2022
Class III · Low risk Terminated

Nandrolone Decanoate

Reason Subpotent Drug

Fagron, Inc NDC 51552-1564-07 D-0864-2022
Class III · Low risk Terminated

Nandrolone Decanoate

Reason Subpotent Drug

Fagron, Inc NDC 51552-1564-05 D-0863-2022